Get Well: World Of Acne

Medicis Announces Approval of Additional strengths of Solodyn (R), Medicis (NYSE: MRX) announced that the U.S. Food and Drug Administration (FDA) approved has additional strengths SOLODYN (R) (minocycline HCl, USP) Extended Release Tablets in 55 mg, 80 mg and 105 mg dosage for the treatment of inflammatory lesions the non-nodular moderate to severe acne vulgaris in [...]